Correlation Between Wuhan General and Minerva Surgical
Can any of the company-specific risk be diversified away by investing in both Wuhan General and Minerva Surgical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wuhan General and Minerva Surgical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wuhan General Gr and Minerva Surgical, you can compare the effects of market volatilities on Wuhan General and Minerva Surgical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wuhan General with a short position of Minerva Surgical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wuhan General and Minerva Surgical.
Diversification Opportunities for Wuhan General and Minerva Surgical
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Wuhan and Minerva is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Wuhan General Gr and Minerva Surgical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Minerva Surgical and Wuhan General is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wuhan General Gr are associated (or correlated) with Minerva Surgical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Minerva Surgical has no effect on the direction of Wuhan General i.e., Wuhan General and Minerva Surgical go up and down completely randomly.
Pair Corralation between Wuhan General and Minerva Surgical
If you would invest (100.00) in Minerva Surgical on December 28, 2024 and sell it today you would earn a total of 100.00 from holding Minerva Surgical or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Wuhan General Gr vs. Minerva Surgical
Performance |
Timeline |
Wuhan General Gr |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Minerva Surgical |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Wuhan General and Minerva Surgical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Wuhan General and Minerva Surgical
The main advantage of trading using opposite Wuhan General and Minerva Surgical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wuhan General position performs unexpectedly, Minerva Surgical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Surgical will offset losses from the drop in Minerva Surgical's long position.Wuhan General vs. Biome Grow | Wuhan General vs. Halo Collective | Wuhan General vs. Cannara Biotech | Wuhan General vs. Avicanna |
Minerva Surgical vs. Dermata Therapeutics | Minerva Surgical vs. Akanda Corp | Minerva Surgical vs. Transcode Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |